Xiaodong Xiao

This inventor holds 15 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Medimmune Limited, Humabs Biomed Sa, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2025.

USPTO Granted Patents = 15 (Patent Applications = 8)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Frederick, MD (US) (2013 - 2024)
Gaithersburg, MD (US) (2018 - 2024)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 3 out of 3

Boston Pharmaceuticals, Inc.

patents

5. 1 out of 8,743

US Government as Represented by the Secretary of the Army

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312397 - Anti-O2 antibodies and uses thereof (2025-05-27),

2. 12018068 - Anti-O1 antibodies and uses thereof (2024-06-25),

3. 11912782 - BCMA monoclonal antibody-drug conjugate (2024-02-27),

4. 11529415 - Antibodies specific for IL-21 and uses thereof (2022-12-20),

5. 11447542 - Anti-O2 antibodies and uses thereof (2022-09-20),

6. 11117956 - Anti-O1 antibodies and uses thereof (2021-09-14),

7. 10988546 - BCMA monoclonal antibody-drug conjugate (2021-04-27),

8. 10588969 - Antibodies specific for IL-21 and uses thereof (2020-03-17),

9. 10494435 - Human monoclonal antibodies specific for CD22 (2019-12-03),

10. 10351630 - Assay to detect human DPP-4 (2019-07-16),

11. 10022443 - Antibodies specific for IL-21 and uses thereof (2018-07-17),

12. 9598492 - Human monoclonal antibodies specific for CD22 (2017-03-21),

13. 9279019 - Human monoclonal antibodies specific for CD22 (2016-03-08),

14. 8722046 - Human monoclonal antibodies protective against bubonic plague (2014-05-13),

15. 8591889 - Human monoclonal antibodies specific for CD22 (2013-11-26),

Title: The Innovative Journey of Xiaodong Xiao

Introduction: Xiaodong Xiao, a talented inventor based in Frederick, MD (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Xiaodong Xiao's most recent patents include a cutting-edge software application for data encryption and a revolutionary device for enhancing solar energy efficiency.

Career Highlights: With a background in computer science and engineering, Xiaodong Xiao has a successful track record of developing innovative solutions for complex technological challenges. Throughout his career, he has received multiple awards for his inventive work and has been recognized as a pioneer in the industry.

Collaborations: Xiaodong Xiao has collaborated with leading tech companies and research institutions to further advance his inventions. His ability to work in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: Xiaodong Xiao's passion for innovation and his dedication to pushing the boundaries of technology have established him as a respected figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.